术中富血小板血浆治疗对髌腱自体骨-髌腱-骨前交叉韧带重建术后供区膝痛的影响:双盲随机对照试验
这项双盲随机对照试验将50例接受骨-髌腱-骨自体前交叉韧带重建的患者随机分为富血小板血浆组(n=27)和假处理组(n=23),术中在髌骨缺损处分别植入富血小板血浆凝胶混合骨碎块或仅骨碎块。结果显示两组在12周、6个月、1年和2年的跪地痛、日常生活活动痛及IKDC评分均无显著差异(P=.08-.83),6个月MRI供区愈合指标也无显著差异(P=.53-.90)。
要点
- 富血小板血浆组与假处理组在各随访时间点的跪地痛、日常生活活动痛和IKDC评分均无显著差异(P=.08-.83)。
- 6个月MRI评估的供区愈合指标(缺损宽度)在两组间无显著差异(P=.53-.90)。
- 无论是否接受富血小板血浆,患者术后跪地痛程度和髌骨缺损大小相似。
核心结论
- 无论术中是否在髌骨缺损处使用富血小板血浆,骨-髌腱-骨自体前交叉韧带重建术后患者持续存在相似水平的跪地痛和髌骨缺损大小。
研究设计与样本
- 双盲随机对照试验,证据等级2级,共纳入50例接受骨-髌腱-骨自体前交叉韧带重建的患者(平均年龄30±12岁)。
- 患者随机分为富血小板血浆组(n=27)和假处理组(n=23),麻醉诱导前抽取10 mL静脉血,假处理组丢弃,富血小板血浆组处理制备富血小板血浆凝胶。
- 富血小板血浆凝胶与供区骨碎块混合后植入髌骨缺损处,假处理组仅植入骨碎块。
主要发现
- 跪地痛、日常生活活动痛和IKDC评分在两组间各时间点均无显著差异(P=.08-.83)。
- 跪地痛从12周到6个月以及从1年到2年有改善(P<.05)。
- IKDC评分从12周到6个月显著改善(P<.001),并持续改善至2年(富血小板血浆组86±19,假处理组89±10)。
- 6个月MRI评估的供区愈合指标(缺损宽度)在两组间无显著差异(P=.53-.90)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Donor site morbidity in the form of anterior knee pain is a frequent complication after bone-patellar tendon-bone (BPTB) autograft anterior cruciate ligament (ACL) reconstruction. Hypothesis/Purpose: The purpose was to examine the effect of the intraoperative administration of platelet-rich plasma (PRP) on postoperative kneeling pain. It was hypothesized that PRP treatment would reduce knee pain. STUDY DESIGN: Randomized controlled trial; Level of evidence, 2. METHODS: Fifty patients (mean ± SD age, 30 ± 12 years) undergoing BPTB ACL autograft reconstruction were randomized to the PRP (n = 27) or sham (n = 23) treatment. In either case, 10 mL of venous blood was drawn before the induction of anesthesia and either discarded (sham) or processed (PRP) for preparation of a PRP gel to be later mixed with donor site bone chips and inserted into the patellar defect. At 12 weeks, 6 months, 1 year, and 2 years after surgery, patients completed International Knee Documentation Committee (IKDC) forms and visual analog scale pain scores for activities of daily living and kneeling. Healing indices at the donor site were assessed by routine noncontrast magnetic resonance imaging (MRI) at 6 months. Mixed-model analysis of variance was used to assess the effect of PRP on patient symptoms and MRI indices of donor site healing, as measured by the width of the donor site defect. RESULTS: Kneeling pain, pain with activities of daily living, and IKDC scores were not different between treatment groups at any of the time intervals ( P = .08-.83). Kneeling pain improved from 12 weeks to 6 months and from 1 to 2 years ( P < .05). IKDC scores improved substantially from 12 weeks to 6 months ( P < .001) and continued to improve to 2 years (PRP, 86 ± 19; sham, 89 ± 10). MRI indices of donor site healing were not different between treatment groups ( P = .53-.90). CONCLUSION: Whether randomized to receive PRP in their patellar defect or not, patients continued to have similar levels of kneeling pain and patellar defect sizes after autograft BPTB ACL reconstruction. Registration: NCT01765712 ( ClinicalTrials.gov identifier).
引用
- Walters BL, Porter DA, Hobart SJ, et al. Effect of Intraoperative Platelet-Rich Plasma Treatment on Postoperative Donor Site Knee Pain in Patellar Tendon Autograft Anterior Cruciate Ligament Reconstruction: A Double-Blind Randomized Controlled Trial. Am J Sports Med. 2018. PMID: 29741923. doi:10.1177/0363546518769295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。